Literature DB >> 3022010

Molecular cloning of the temperature-sensitive 371 Kirsten murine sarcoma virus and expression in Escherichia coli of the mutant and wild-type viral Kirsten ras p21 proteins.

R B Stein, J Y Tai, E M Scolnick.   

Abstract

Rodent fibroblasts infected with the ts371 Kirsten murine sarcoma virus (KiMuSV) are temperature sensitive for the maintenance of transformation because of the production of an abnormal p21 protein. We cloned the ts371 KiMuSV provirus from the genome of a conditionally transformed nonproducer cell line, ts371 KiMuSV NRK clone 5 (T. Y. Shih, M. O. Weeks, H. A. Young, and E. M. Scolnick, J. Virol. 31:546-556, 1979). The molecularly cloned virus had 1,000-fold lower transformed focus-forming activity at 39 degrees C than at 34 degrees C. The ts371-v-Ki-ras gene differed from the wild type (wt) by a single point mutation, resulting in the substitution of arginine for glutamine at amino acid residue 43 of the encoded p21. A second difference from the published sequence for wt v-Ki-ras (N. Tsuchida, T. Ryder, and E. Ohtsubo, Science 217:937-939, 1982) at amino acid residue 37 was found. However, on sequencing the wt v-Ki-ras in this region, we found that it also contained a glutamate at residue 37. Preliminary characterization of bacterially expressed wt and ts371-v-Ki-ras p21 proteins is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022010      PMCID: PMC288958     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Sequence of the alpha subunit of photoreceptor G protein: homologies between transducin, ras, and elongation factors.

Authors:  M A Lochrie; J B Hurley; M I Simon
Journal:  Science       Date:  1985-04-05       Impact factor: 47.728

2.  Homologies between signal transducing G proteins and ras gene products.

Authors:  J B Hurley; M I Simon; D B Teplow; J D Robishaw; A G Gilman
Journal:  Science       Date:  1984-11-16       Impact factor: 47.728

3.  Lambda replacement vectors carrying polylinker sequences.

Authors:  A M Frischauf; H Lehrach; A Poustka; N Murray
Journal:  J Mol Biol       Date:  1983-11-15       Impact factor: 5.469

4.  Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations.

Authors:  D J Capon; P H Seeburg; J P McGrath; J S Hayflick; U Edman; A D Levinson; D V Goeddel
Journal:  Nature       Date:  1983 Aug 11-17       Impact factor: 49.962

5.  Viral Harvey ras p21 expressed in Escherichia coli purifies as a binary one-to-one complex with GDP.

Authors:  M Poe; E M Scolnick; R B Stein
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

6.  Structure of the GDP domain of EF-Tu and location of the amino acids homologous to ras oncogene proteins.

Authors:  F Jurnak
Journal:  Science       Date:  1985-10-04       Impact factor: 47.728

7.  Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects.

Authors:  I S Sigal; J B Gibbs; J S D'Alonzo; G L Temeles; B S Wolanski; S H Socher; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

8.  Homologies in the primary structure of GTP-binding proteins: the nucleotide-binding site of EF-Tu and p21.

Authors:  R Leberman; U Egner
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

9.  Characterization of functional domains of p21 ras by use of chimeric genes.

Authors:  E D Schejter; B Z Shilo
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

View more
  2 in total

1.  Effect of synthetic peptides representing the hypervariable region of p21ras on Xenopus laevis oocyte maturation.

Authors:  I Soto-Cruz; A I Magee
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

2.  Evidence for a role of phosphatidylcholine-hydrolysing phospholipase C in the regulation of protein kinase C by ras and src oncogenes.

Authors:  I Diaz-Laviada; P Larrodera; M T Diaz-Meco; M E Cornet; P H Guddal; T Johansen; J Moscat
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.